SFCM
PCVX icon

Seven Fleet Capital Management’s Vaxcyte PCVX Stock Holding History

Seven Fleet Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.3M Buy
108,450
+83,085
+328% +$4.51M 1.98% 9
2025
Q4 		$1.17M Buy
+25,365
New +$1.13M 0.79% 23

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Seven Fleet Capital Management's PCVX Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Vaxcyte (PCVX) stake by 328% in Q1 2026, buying an estimated $4.51M and bringing the position to 108,450 shares worth $6.3M. The position accounts for 1.98% of the portfolio, ranked #9.

Seven Fleet Capital Management first reported a position in PCVX in Q4 2025 and has held it in 2 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Seven Fleet Capital Management held 108,450 shares of Vaxcyte worth $6.3M as of Q1 2026.
  • Seven Fleet Capital Management bought 83,085 Vaxcyte shares in Q1 2026, an estimated $4.51M.
  • Vaxcyte made up 1.98% of Seven Fleet Capital Management's portfolio in Q1 2026, its #9 holding.
  • Seven Fleet Capital Management first reported a position in Vaxcyte in Q4 2025 and has held it in 2 quarters since.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.